The endogenous pathway of MHC class II antigen presentation

Immunological Reviews

Volumn , Issue 151, 1996, Pages 51-79

  Lechler, Robert ^a,b   Aichinger, Gerald ^a   Lightstone, Liz ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HLA D ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS PROTEIN; HLA ANTIGEN CLASS 2;

ALLELE; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELL SURFACE; CYTOSOL; DENDRITIC CELL; DROSOPHILA; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN TRANSPORT; REVIEW; T LYMPHOCYTE; ANIMAL; GENETICS; IMMUNOLOGY;

ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS;

EID: 0029658575     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065x.1996.tb00703.x     Document Type: Review

References (121)

1. Aichinger, G., Karlsson, L., Vestberg, M., Teyton, L., Jackson, M. R., Lechler, R.I., Peterson, P.A. (1996). MHC class II molecules can transport unfolded proteins from the endoplasmic reticulum to an endosomal antigen processing compartment. (submitted)
2. Anderson, M.S., Swier, K., Arneson, L., & Miller, J. (1993). Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J. Exp. Med. 178, 1959-1969.
3. Anderson, K.S. & Cresswell, P. (1994). A role for calnexin (IP90) in the assembly of class II molecules. EMBO J. 13, 675-682.
4. Arunachalam, B., & Cresswell, P. (1995). Molecular requirements for the interaction of class II major histocompatibility complex molecules and invariant chain with calnexin. J. Biol. Chem. 270, 2784-90.
5. Attaya, M., Jameson, S., Martinez, C.K., Hermel, E., Aldrich, C., Forman, J., Fischer Lindahl, K., Bevan, M.J., & Monaco, J.J. (1992). Ham-2 corrects the class I antigenprocessing defect in RMA-S cells. Nature 355, 647-649.
6. Avva, R. R., & Cresswell, P. (1994). In vivo and in vitro formation and dissociation of HLADR complexes with invariant chain-derived peptides. Immunity 1, 763-74.
7. Bakke, O. & Dobberstein, B. (1990). MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.
8. Bartido, S., Diment, S., & Reiss, C. S. (1995). Processing of a viral glycoprotein in the endoplasmic reticulum for class II presentation. Eur. J. Immunol. 25, 2211-2219.
9. Bijlmakers, M.-J., J.E., Benaroch, P., & Ploegh, H.L. (1994a). Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180, 623-629.
10. Bijlmakers, M.-J.,J.E., Benaroch, P., & Ploegh, H.L. (1994b). Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain. EMBO J. 13, 2699-2707
11. b antigen. Eur. J. Immunol. 21, 1411-1417.
12. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177, 1699-712.
13. Blum, J.S. & Cresswell, P. (1988). Role for intracellular protoases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85, 3975-3979.
14. Bodmer, H., Viville, S., Benoist, C., & Mathis, D. (1994). Diversity of endogenous epitopes bound to MHC class II moleucles limited by invariant chain. Science 263, 1284-1286.
15. Bohm, W., Schirmbeck, R., Elbe, A., Melber, K., Diminky, D., Kraal, G., van Rooijen, N., Barenholz, Y., & Reimann, J. (1995). Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155, 3313-21.
16. Bonnerot C., Marks, M.S., Cosson, P., Robertson, E.J., Bikoff, E.K., Germain, R.N., & Bonifacino, J.S. (1994). Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J. 13, 934-944.
17. Brooks, A. G., & McCluskey, J. (1993). Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. J. Immunol. 150, 3690-7.
18. Brooks, A. G., Campbell, P. L., Reynolds, P., Gautam, A. M., & McCluskey, J. (1994). Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153, 5382-92.
19. Brooks, A., Hartley, S., Kjer-Nielsen, L., Perera, J., Goodnow, C.C., Basten, A., & McCluskey, J. (1991). Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc. Natl. Acad. Sci. USA 88, 3290-3294.
20. Brown, W. J., Goodhouse, J. & Farquhar, M. G. (1986). Mannose-6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes. J. Cell Biol. 103, 1235-1247
21. Busch, R., Cloutier, I., Sekaly, R.-P., & Hammerling, G. J. (1996). Invariant chain protects class II histocompalibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15, 418-428.
22. Busch, R., Vturina, I. Y., Drexler, J., Momburg, F. & Hammerling, G. J. (1995). Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain. Eur. J. Immunol. 25, 48-53.
23. Carbone, F.R., Hosken, N.A., Moore, M.W., & Bevan, M.J. (1989). Class I MHC-reslricted cytotoxic responses to soluble protein antigen. Cold Spring Harbor Symp. Quant. Biol. 54, 551-556.
24. Carmichael, P., Kerr, L.-A., Kelly, A., Lombardi, G., Uchansku-Zeigler, B., Ziegler, A., Trowsdale, J. & Lechler, R. (1996). The TAP complex influences allorecognition of class II MHC molecules. Hum. Immunol., in press.
25. Ceman, S., Rudersdorf, R. A., Petersen, J. M., & DeMars, R. (1995). DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J. Immumol. 154, 2545-56.
26. Chapman, R. E. & Munro, S. (1994). Retrieval of TGN proteins from the cell surface requires endosomal acidification. EMBO J. 13, 2305-2312.
27. Chen, B. P., Madrigal, A., & Parham, P. (1990). Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp. Med. 172, 779-88.
28. Chiang, H.-L., Terlecky, S.R., Plant, C.P., & Dice, J.F. (1989). A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 246, 382-385.
29. Chicz, R.M., Urban, R.G., Gorga, J.C., Vignali, D.A.A., Lane, W.S., & Strominger, J.L. (1993). Specificity and promiscuity among naturally processed peptides hound to HLA-DR alleles. J. Exp. Med. 178, 27-47.
30. Claesson-Welsh, L. & Peterson, P.A. (1985). Implications of the invariant γ-chain on the intracellular transport of class II histocompatibility antigens. J. Immunol. 135, 3551-3557
31. Cotner, T., Mellins, E., Johnson, A. H., & Pious, D. (1991). Mutations affecting antigen processing impair class II-restricted allorecognition. J. Immunol. 146, 414-7.
32. DeMars, R., Chang, C.C., Shaw, S., Reitnauer, R.J., & Sondel, P.M. (1984). Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum. Immunol. 11, 77-97.
33. Denzin, L. K., & Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class Il alpha beta dimers and facilitates peptide loading. Cell 82, 155-65.
34. Denzin, L. K., Robbins, N. F., Carboy Newcomb, C., & Cresswell, P. (1994). Assembly and intracellular transport of HLA-DM and correction of the class II antigen processing detect in T2 cells. Immunity 1, 595-606.
35. Dodi, A.I., Brett, S., Nordeng, T., Sidhu, S., Batchelor, R.J., Lombardi, G., Bakke, O., & Lechler, R.I. (1994). The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Eur. J. Immunol. 24, 1632-1639
36. Germain, R.N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
37. Germain, R.N. & Rinker, A.G.J. (1993). Peptide binding inhibits protein aggregation of invariant-chain free class Il dimers and promotes surface expression of occupied molecules. Nature 363, 725-728.
38. Gorga, J.C., Horejsi, V., Johnson, D.R., Raghupathy, R., & Strominger, J.L. (1987). Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262, 16087-16097.
39. Hammerling, G. J. & Moreno, J. (1990). The function of the invariant chain in antigen presentation by MHC class II molecules. Immunol. Today 11, 337-40.
40. Harding, C.V. & Song, R. (1994). Phagocytic processing of exogenous paniculate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153, 4925-4933.
41. + T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression. Int. Immunol., 7, 1505-1513.
42. Hewlett, L.J., Prescott, A.R., & Watts, C. (1994). The coated pit and macropinocytic pathways serve distinct endosome populations. J. Cell Biol. 124, 689-703.
43. Hitzel, C., van Endert, P., & Koch, N. (1995). Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain. J. Immunol. 154, 1048-56.
44. Humbert, M., Bertolino, P., Forquet, P., Rabourdin Combe, C., Gerlier, D., Davoust, J., & Salamero, J. (1993). Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. Eur. J. Immunol. 23, 3167-72.
45. Hunt, D.F., Michel, H., Dickinson, T.A., Shabanowitz, J., Cox, A.L., Sakaguchi, K., Appella, E., Grey, H.M., & Sette, A. (1992). Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256, 1817-1820.
46. Jackson, M.R., Nilsson, T., & Peterson, P.A. (1990). Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-3160.
47. Jacobson, S., Sekaly, R.P., Jacobson, C.L., McFarland, H.F., & Long, E.O. (1989). HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytoloxic T cells. J. Virol. 63, 1756-1762.
48. Jensen, P.E. (1993). Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150, 3347-3356.
49. Karlsson, L., Peleraux, A., Lindstedt, R., Liljedahl, M., & Peterson, P. A. (1994). Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266, 1569-73.
50. Kelly, A. P., Monaco, J. J., Cho, S. G., & Trowsdale, J. (1991). A new human HLA class IIrelated locus. DM. Nature 353, 571-3.
51. Kittlesen, D.J., Brown, L.R., Bracicale, V.L., Sambrook, J.P., Gething, M.-J., & Braciale, T.J. (1993). Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza haemagglutinin transport muiants. J. Exp. Med. 177, 1021-1030.
52. Koch, N. & Harris, A.W. (1984). Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. J. Immunol. 132, 12-15.
53. Koch, N., Moldenhauer, G., Hofmann, W.J., & Möller, P. (1991). Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J. Immunol. 147, 2643-2651.
54. Kovacsovics-Bankowski, M., & Rock, K. L. (1995). A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243-6.
55. Kvist, S., Wiman, K., Claesson, L., Peterson, P., & Dobberstein, B. (1982). Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29, 61-69.
56. Lamb, C. A., & Cresswell, P. (1992). Assembly and transport properties of invariant chain trimers. J. Immunol. 148, 3478-82.
57. Lechler, R. & Lombardi, G. (1990). The structural basis of alloreactivity. Immunol. Res. 9, 135-146
58. Lee, P., Matsueda, G.R., & Allen, P.M. (1988). T cell recognition of fibrinogen. A determinant on the Aα-chain does not require processing. J. Immunol. 140, 1063-1068.
59. Lightstone, L., Hargraeves, R., Bobeck, G., Peterson, M., Aichinger, G., Lombardi, G., & Lechler, R. (1996). HLA-DR molecules display a distinct array of peptides in the absence of the invariant chain, which is influenced by the presence or absence of HLA-DM. (submitted).
60. Lindstedl, R., Liljedahl, M., Peleraux, A., Peterson, P. A., & Karlsson, L. (1995). The MHC class II molecule, Hα-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3, 561-572.
61. Loss, G. J., Elias, C. G., Fields, P. E., Ribaudo, R. K., McKisic, M., & Sant, A. J. (1993). Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways. J. Exp. Med. 178, 73-85.
62. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S.L., Quaranta, V., & Peterson, P.A. (1990). Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
63. Malnati, M.S., Ceman, S., Weston, M., DeMars, R., & Long, E.O. (1993). Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J. Immunol. 151, 6751-6756.
64. Marks, M.S., Germain, R.N., & Bonifacino, J.S. (1995). Transient aggregation of major histocompatibility complex class II chains during assembly in normal spleen cells J. Biol. Chem. 270, 10475-10481.
65. Matzinger, P. & Bevan, M.J. (1977). Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell. Immunol. 29, 1-5.
66. Mellins, E., Cameron, P., Amaya, M., Goodman, S., Pious, D., Smith, L., & Arp, B. (1994). A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J. Exp. Med. 179, 541-9.
67. Mellins, E., Kempin, S., Smith, L., Monji, T., & Pious, D. (1991). A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J. Exp. Med. 174, 1607-15.
68. Mellins, E., Smith, L., Arp, B., Corner, T., Cells, E., & Pious, D. (1990). Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343, 71-4.
69. Miller, J., & Germain, R. N. (1986). Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164, 1478-1489.
70. Momburg, F., Koch, N., Möller, P., Moldenhauer, G., Butcher, G.W., & Hämmerling, G.J. (1986). Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-γ. J. Immunol. 136, 940-948.
71. Monji, T., McCoimack, A. L., Yates, J. R. R., & Pious, D. (1994). Invariant cognate peptide exchange restores class II dimer stability in HLA-DM mutants. J. Immunol. 153, 4468-77.
72. Moore, M.W., Carbone, F.R., & Bevan, M.J. (1988). Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54, 777-785.
73. Moreno, J., Vignali, D. A., Nadimi, F., Fuchs, S., Adorini, L., & Hämmerling, G. J. (1991). Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147, 3306-13.
74. Morkowski, S., Goldrath, A. W., Eastman, S., Ramachandra, L., C., F. D., Whiteley, P., & Rudensky, A. Y. (1995). T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J. Exp. Med. 182, 1403-1413.
75. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J. J., & Mellins, E. (1994). An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-4.
76. Morrison, L.A., Lukacher, A.E., Braciale, V.L., Fan, D.P., & Braciale, T.J. (1986). Differences in antigen presentation to MHC class I- and class II-restricted influenza virusspecific cytolytic T lymphocyte clones. J. Exp. Med. 163, 903-921.
77. Munro, S. & Pelham, H.R.B. (1987). A C-terminal signal prevents secretion of luminal ER proteins. Cell 48, 899-907.
78. Naujokas, M. F., Morin, M., Anderson, M. S., Peterson, M., & Miller, J. (1993). The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 74, 257-68.
79. k. Proc. Natl. Acad. Sci. USA 89, 7380-7383.
80. Newcomb, J.R. & Cresswell, P. (1993). Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J. Immunol. 150, 499-507.
81. Nowell, J., Quaranta, V. (1985). Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of in variant chains from α-β dimers in B cells. J. Exp. Med. 162, 1371-1376.
82. Nuchtern, J. G., Biddison, W. E., & Klausner, R. D. (1990). Class II MHC molecules can use the endopenous pathway of antigen presentation. Nature 343, 74-6.
83. Pessara, U., Momburg, F., & Koch, N. (1988). Cooperative effect of interferon-gamma and tumor necrosis factor-α on the induction of the class II antigen-associated invariant chain expression. Eur. J. Immunol. 18, 1719-1726.
84. Pinet. V., Vergelli, M., Martin, R., Bakke, O., & Long, E. O. (1995). Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375, 603-6.
85. Rath, S., Lin, R. H., Rudensky, A., & Janeway, C. J. (1992). T and B cell receptors discriminate major histocompatibility complex class II conformations influenced by the invariant chain. Eur. J. Immunol. 22, 2121-7.
86. Reis e Sousa, C., & Germain, R. N. (1995). Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 82, 841-51.
87. Riberdy, J. M., Newcomb, J. R., Surman, M. J., Barbosa, J. A., & Cresswell, P. (1992). HLA DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360, 474-477.
88. Roche, P.A. & Cresswell, P. (1990). Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618.
89. Roche, P.A., Marks, M.S., & Cresswell, P. (1991). Formation of a nine-subunit complex by HLA class II glycoproieins and the invariant chain. Nature 354, 392-394.
90. Roche, P.A., Teletski, C.L., Karp, D.R., Pinet, V., Bakke, O., & Long, E.O. (1992). Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J. 11, 2841-2847.
91. Roche, P.A., Teletski, C.L., Stang, E., Bakke, O., & Long, E.O. (1993). Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. PNAS 90, 8581-8585.
92. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., & Janeway, C.A., Jr. (1991). Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
93. Rudensky, A. Y., Maric, M., Eastman, S., Shoemaker, L., DeRoos, P. C., & Blum, J. S. (1994). Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1, 585-94.
94. Sallusto, F., Cella, M., Danieli, C., & Lanzaveechia, A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by eytokines and bacterial products [see comments]. J. Exp. Med. 182, 389-400.
95. Sanderson, F., Thomas, C., Neefjes, J. J. & Trowsdale, J. (1996). Association between HLADM and HLA-DR in vivo. Immunity 4, 1-20.
96. Sanderson, F., Kleiimeer, M. J., Kelly, A., Verwoerd, D., Tulp, A., Neefjes, J. J., Geuze, H. J., & Trowsdale, J. (1994). Accumulation of HLA-DM. a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-9.
97. Schafer, P.H. & Pierce, S.K. (1994). Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1, 699-707.
98. Schaiff, W., Hruska, K., Bono, C., Shuman, S., & Schwartz, B. (1992). HLA-DR associates with stress-specific proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp. Med. 176, 657-666.
99. Schneider, H.-J., Opel, Balhausen, W., Henkes, W., Steinlein, & Reske, K. (1987). Synthesis and expression of MHC class II moleucles in the absence of attached invariant chains by recombinant interferon-γ-activated bone marrow-derived macrophages. Eur. J. Immunol. 17, 1235-1242.
100. Schutze, M.-P., Peterson, P.A., & Jackson, M.R. (1994). An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J. 13, 1696-1705.
101. Sekaly, R., Tonnelle, C., Strubin, M., Mach, B., & Long, E. (1986). Cell surface expression of Class II histocompatibility antigens occurs in the absence of the invariant chain. J. Exp. Med. 164, 1490-1504.
102. Seite, A., Adorini, L., Colon, S.M., Buus, S., & Grey, H.M. (1989). Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143, 1265-1267.
103. Sette, A., Southwood, S., Miller, J., & Appella, E. (1995). Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med .181, 677-83.
104. Shaman, J., von Scheven, E., Morris, P., Chang, M. D., & Mellins, E. (1995). Analysis of HLA-DMB mutants and -DMB genomic structure. Immunogenetics 41, 117-24.
105. Simonsen, A., Momburg, F., Drexler, J., Hammerling, G. J., & Bakke, O. (1993). Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. Int. Immunol. 5, 903-17.
106. Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., & Zaller, D. M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-6.
107. Smiley, S. T., Laufer, T. M., Lo, D., Glimcher, L. H., & Grusby, M. J. (1995). Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation. Int. Immunol. 7, 665-677.
108. Smiley, S., Rudensky, A. Y., Glimcher, L. H., & Grusby, M. J. (1996). Truncation of the class II β-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes. Proc. Natl. Acad. Sci. USA 93, 241-44.
109. Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend, A., & DeMars, R. (1992). Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355, 644-646.
110. Staerz, U. D., Karasuyama, H., Garner, A. M. (1987). Cytotoxic T lymphocytes against a soluble protein. Nature 329, 449-445.
111. Stebbins, C. C., Loss, G. E., Jr., Elias, C. G., Chervonsky, A., & Sant, A. J. (1995). The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 181, 223-34.
112. Stern, L.J. & Wiley, D.C. (1992). The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68, 465-477.
113. Strubin, M., Long. E.O., & Mach, B. (1986). Two forms of the Ia antigen-associated invariant chain results from alternative initiations at two in-phase AUGs. Cell 47, 619-625.
114. Sugita, M., & Brenner, M. B. (1995). Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270, 1443-8.
115. Swain, S. L. (1983). T cell subsets and the recognition of MHC class. Immunol. Rev. 74, 129-142.
116. Suto, R., & Srivastava, P. K. (1995). A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-8.
117. Teyton, L., O'Sullivan, D., Dickson, P.W., Lotteau, V., Seite, A., Fink, P., & Peterson, P.A. (1990). Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348, 39-44.
118. Vidal, K., Samarut, C., Magaud, J.-P., Revillard, J.-P. & Kaiserlian, D. (1993). Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells J. Immunol. 151, 4642-4650.
119. Viville, S., Neefjes, J.J., Lotteau, V., Dierich, A., Lemour, M., Ploegh, H., Benoist, C., & Mathis, D. (1993). Mice lacking the MHC class II-associated invariant chain. Cell 72, 635-648.
120. Weiss, S. & Bogen, B. (1991). MHC class II-restricted presentation of intracellular antigen. Cell 64, 767-776.
121. Wolf, P. R., & Ploegh, H. L. (1995). Antigen presentation. DM exchange mechanism [news]. Nature 376, 464-5.